307 related articles for article (PubMed ID: 35231177)
1. Current Developments and Challenges of mRNA Vaccines.
Chen J; Chen J; Xu Q
Annu Rev Biomed Eng; 2022 Jun; 24():85-109. PubMed ID: 35231177
[TBL] [Abstract][Full Text] [Related]
2. The Current Landscape of mRNA Vaccines Against Viruses and Cancer-A Mini Review.
Ladak RJ; He AJ; Huang YH; Ding Y
Front Immunol; 2022; 13():885371. PubMed ID: 35603213
[TBL] [Abstract][Full Text] [Related]
3. The clinical progress and challenges of mRNA vaccines.
Yu MZ; Wang NN; Zhu JQ; Lin YX
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1894. PubMed ID: 37096256
[TBL] [Abstract][Full Text] [Related]
4. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
[TBL] [Abstract][Full Text] [Related]
5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
6. Vaccines' New Era-RNA Vaccine.
Zhou W; Jiang L; Liao S; Wu F; Yang G; Hou L; Liu L; Pan X; Jia W; Zhang Y
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632102
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 mRNA vaccines: Platforms and current developments.
Szabó GT; Mahiny AJ; Vlatkovic I
Mol Ther; 2022 May; 30(5):1850-1868. PubMed ID: 35189345
[TBL] [Abstract][Full Text] [Related]
8. mRNA vaccines against infectious diseases and future direction.
Aleem MT; Munir F; Shakoor A; Gao F
Int Immunopharmacol; 2024 Jun; 135():112320. PubMed ID: 38788451
[TBL] [Abstract][Full Text] [Related]
9. [mRNA vaccines for infectious diseases: research progress and applications].
Qin F; Ren N; Cheng W; Wei H
Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):3966-3984. PubMed ID: 37877385
[TBL] [Abstract][Full Text] [Related]
10. Clinical Development of mRNA Vaccines: Challenges and Opportunities.
August A; Brito L; Paris R; Zaks T
Curr Top Microbiol Immunol; 2022; 440():167-186. PubMed ID: 35906319
[TBL] [Abstract][Full Text] [Related]
11. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.
Rouf NZ; Biswas S; Tarannum N; Oishee LM; Muna MM
RNA Biol; 2022; 19(1):386-410. PubMed ID: 35354425
[TBL] [Abstract][Full Text] [Related]
12. mRNA vaccines for infectious diseases: principles, delivery and clinical translation.
Chaudhary N; Weissman D; Whitehead KA
Nat Rev Drug Discov; 2021 Nov; 20(11):817-838. PubMed ID: 34433919
[TBL] [Abstract][Full Text] [Related]
13. Introduction to RNA Vaccines Post COVID-19.
Kramps T
Methods Mol Biol; 2024; 2786():1-22. PubMed ID: 38814388
[TBL] [Abstract][Full Text] [Related]
14. Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited].
Jawalagatti V; Kirthika P; Lee JH
Front Immunol; 2022; 13():884862. PubMed ID: 35592330
[TBL] [Abstract][Full Text] [Related]
15. mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.
Le T; Sun C; Chang J; Zhang G; Yin X
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215994
[TBL] [Abstract][Full Text] [Related]
16. Advances in mRNA vaccines.
Li M; Wang Z; Xie C; Xia X
Int Rev Cell Mol Biol; 2022; 372():295-316. PubMed ID: 36064266
[TBL] [Abstract][Full Text] [Related]
17. Messenger RNA-Based Vaccines Against Infectious Diseases.
Alameh MG; Weissman D; Pardi N
Curr Top Microbiol Immunol; 2022; 440():111-145. PubMed ID: 32300916
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases.
Yang L; Tang L; Zhang M; Liu C
Front Immunol; 2022; 13():896958. PubMed ID: 35928814
[TBL] [Abstract][Full Text] [Related]
19. Innate immune mechanisms of mRNA vaccines.
Verbeke R; Hogan MJ; Loré K; Pardi N
Immunity; 2022 Nov; 55(11):1993-2005. PubMed ID: 36351374
[TBL] [Abstract][Full Text] [Related]
20. The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines.
Wei J; Hui AM
Cancer Treat Rev; 2022 Jun; 107():102405. PubMed ID: 35576777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
